Immunoassays Market to Increase by USD 58.2 Billion by 2033, North America to Occupy 38.5% of Market Share - Market.us
January 24, 2024 06:58 ET
|
Market.Us
New York, Jan. 24, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Immunoassays market size is forecasted to exceed USD 58.2 Billion by 2033, with a promising CAGR of 6.2% from 2024 to 2033. ...
Radioactive Tracer Market is expected to hit $5.26 Billion by 2031 Globally, at a CAGR of 7.2%, says Coherent Market Insights
January 24, 2024 06:54 ET
|
CMI
Burlingame, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Radioactive Tracer Market in terms of revenue was valued to be reach $3.24 Billion in 2023 and is poised to reach $5.26 Billion by 2031, growing at a...
Global Microsurgery Market Size To Exceed USD 3.6 Billion By 2032 | CAGR Of 5.5%
January 24, 2024 03:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Global Microsurgery Market Size is to Grow from USD 2.1 Billion in 2022 to USD 3.6 Billion by 2032, at a Compound Annual Growth Rate...
Medical Devices Sector: 2023 Update on Contrast Agents Pipeline Reveals Key Companies and Emerging Technologies
January 23, 2024 08:13 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report...
4DMT Receives Rare Pediatric Disease Designation from FDA for Aerosolized 4D-710 for Treatment of Cystic Fibrosis Lung Disease
January 23, 2024 08:00 ET
|
4D Molecular Therapeutics, Inc.
4D-710 has demonstrated promising, reproducible, CFTR expression significantly above normal levels for seven patients across Cohorts 1 & 2 (1E15-2E15 vg) and durable improvement or stabilization...
ONL Therapeutics to Present on ONL1204 in Podium Presentation at the 47th Annual Meeting of the Macula Society
January 23, 2024 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Jan. 23, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
HEALWELL AI Provides Corporate Update Highlighting its Growth and Value Creation Strategy and Recent Commercial Successes
January 23, 2024 02:30 ET
|
HEALWELL AI Inc.
HEALWELL AI Provides Corporate Update Highlighting its Growth and Value Creation Strategy and Recent Commercial Successes
Vitreous Tamponades Market Forecasted to Reach USD 226.24 Million by 2030: Reveals Latest Research and Trend Analysis
January 23, 2024 00:43 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Vitreous Tamponades Market by Product (Gaseous Tamponades, Liquid Tamponades), End-user (Hospitals, Ophthalmology Clinics) - Forecast 2024-2030"...
Ophthalmic Diagnostic Equipment Global Pipeline Analysis, 2023 and Beyond: Reveals Key Advances in Eye Health Technology
January 22, 2024 18:23 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Ophthalmic Diagnostic Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,...
Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and Utilization of IL-17 Inhibitors
January 22, 2024 10:47 ET
|
Spherix Global Insights
EXTON, PA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Since the first US FDA-approved tumor necrosis factor (TNF) inhibitor in 2002 for the treatment of psoriatic arthritis (PsA), TNF’s have upheld their...